Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar;109(12):209-14.
doi: 10.3238/arztebl.2012.0209. Epub 2012 Mar 23.

Achalasia--a disease of unknown cause that is often diagnosed too late

Affiliations
Review

Achalasia--a disease of unknown cause that is often diagnosed too late

Ines Gockel et al. Dtsch Arztebl Int. 2012 Mar.

Abstract

Introduction: Many physicians are inadequately familiar with the clinical features of achalasia. Often, it is not diagnosed until years after the symptoms arise. This is unfortunate, because a delay in diagnosis worsens the prognosis.

Methods: Selective review of the literature.

Results: Achalasia has a lifetime prevalence of 1:10 000. It is a neurodegenerative disorder in which the neurons of the myenteric plexus are lost, leading to dysfunction of the lower esophageal sphincter and to a derangement of esophageal peristalsis. In the final stage of achalasia, esophageal motility is irreversibly impaired, and complications ensue because of the retention of food that is no longer transported into the stomach. Aspiration causes pulmonary disturbances in up to half of all patients with achalasia. There may also be inflammation of the esophageal mucosa (retention esophagitis); this, in turn, is a risk factor for esophageal cancer, which arises in 4% to 6% of patients. The cause of achalasia is not fully known, but autoimmune processes appear to be involved in patients with a genetic susceptibility to the disease.

Conclusion: Achalasia should be diagnosed as early as possible, so that complications can be prevented. In addition, guidelines should be established for cancer prevention in achalasia patients. Currently ongoing studies of the molecular causes of achalasia will probably help us understand its pathophysiology.

PubMed Disclaimer

Figures

Figure
Figure
As a rule, endoscopy is the first step in diagnosing the cause of dysphagia. It can also be used to rule out secondary achalasia, e.g. inflammation, stenosis, or tumors, and to obtain tissue biopsies. However, if there are grounds in the patient’s medical history for suspecting a stricture, e.g. caused by radiation or chemical burns, a barium swallow and X-ray of the esophagus are recommended first, as endoscopy poses a higher risk of perforation. In such cases, endoscopy is performed only to rule out secondary achalasia. Once secondary achalasia has been ruled out endoscopically, an esophageal manometry and/or barium swallow and X-ray of the esophagus are performed
Figure 2
Figure 2
Characteristic X-ray of achalasia patient following barium swallow, with bird’s beak. At an advanced stage of achalasia, esophageal dilatation can be seen even on a chest X-ray with no contrast
Figure 3
Figure 3
Manometry results in achalasia: increased resting tone of LES with absence of relaxation on swallowing and simultaneous contractions of the tubular esophagus; “W” indicates a wet swallow. The manometry probe can measure the amplitude of esophageal contractions at three different locations in the tubular esophagus (top three sections); the bottom section provides a direct representation of the region of the lower esophageal sphincter (absence of relaxation). The y-axis shows the pressure in mm Hg, and the x-axis the time in second

Comment in

  • Two arguments in favor of surgery.
    Rabenstein T. Rabenstein T. Dtsch Arztebl Int. 2012 Aug;109(31-32):534. doi: 10.3238/arztebl.2012.0534a. Epub 2012 Aug 6. Dtsch Arztebl Int. 2012. PMID: 23049649 Free PMC article. No abstract available.
  • No new therapeutic approach.
    Stelzner F. Stelzner F. Dtsch Arztebl Int. 2012 Aug;109(31-32):534. doi: 10.3238/arztebl.2012.0534b. Epub 2012 Aug 6. Dtsch Arztebl Int. 2012. PMID: 23049650 Free PMC article. No abstract available.

References

    1. Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005;100:1404–1414. - PubMed
    1. Gockel HR, Schumacher J, Gockel I, Lang H, Haaf T, Nothen MM. Achalasia: will genetic studies provide insights? Hum Genet. 2010;128:353–364. - PubMed
    1. Vela MF, Vaezi MF. Cost-assessment of alternative management strategies for achalasia. Expert Opin Pharmacother. 2003;4:2019–2025. - PubMed
    1. Eckardt VF. Clinical presentations and complications of achalasia. Gastrointest Endosc Clin N Am. 2001;11:281–292. - PubMed
    1. Eckardt VF, Kohne U, Junginger T, Westermeier T. Risk factors for diagnostic delay in achalasia. Dig Dis Sci. 1997;42:580–585. - PubMed

MeSH terms